63 related articles for article (PubMed ID: 3971397)
21. Preoperative chemotherapy in the treatment of inflammatory breast cancer.
Keiling R; Guiochet N; Calderoli H; Hurteloup P; Krzisch C
Prog Clin Biol Res; 1985; 201():95-104. PubMed ID: 4095121
[No Abstract] [Full Text] [Related]
22. [Subclinical heart damage caused by adjuvant anthracycline chemotherapy].
Dunst J
Strahlenther Onkol; 2002 Feb; 178(2):110-1. PubMed ID: 11942035
[No Abstract] [Full Text] [Related]
23. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
Chen GY; Lee JY; Chen WC
Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
[No Abstract] [Full Text] [Related]
24. Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors.
Cheng E; Berthold DR; Moore MJ; Duran I
Acta Oncol; 2009; 48(3):475-7. PubMed ID: 18932096
[No Abstract] [Full Text] [Related]
25. [The use of Cardioxan as a cardioprotective agent during antitumor chemotherapy].
Lichinitser MR; Vyshinskaia GV; Min'kov ED; Nakhalova TA; Odzharova AA; Garin AM
Ter Arkh; 1994; 66(7):54-6. PubMed ID: 7985130
[No Abstract] [Full Text] [Related]
26. Potential risk of a common hereditary thrombophilia and adjuvant chemotherapy for low-stage breast cancer.
Ely SF
J Clin Oncol; 2005 Jun; 23(18):4242-3. PubMed ID: 15961781
[No Abstract] [Full Text] [Related]
27. [Neoadjuvant chemotherapy of patients with breast carcinoma].
Jakesz R; Taucher S; Gnant M; Gebhard B; Kandioler D; Rudas M; Djavanmard M; Steger G
Zentralbl Chir; 1998; 123 Suppl 5():147-50. PubMed ID: 10063601
[TBL] [Abstract][Full Text] [Related]
28. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.
Falanga A; Levine MN; Consonni R; Gritti G; Delaini F; Oldani E; Julian JA; Barbui T
Thromb Haemost; 1998 Jan; 79(1):23-7. PubMed ID: 9459316
[TBL] [Abstract][Full Text] [Related]
29. Eosinophilic pustular folliculitis induced by chemotherapy.
Laing ME; Laing TA; Mulligan NJ; Keane FM
J Am Acad Dermatol; 2006 Apr; 54(4):729-30. PubMed ID: 16546603
[No Abstract] [Full Text] [Related]
30. Biphasic interaction of phenytoin with warfarin.
Levine M; Sheppard I
Clin Pharm; 1984; 3(2):200-3. PubMed ID: 6723231
[No Abstract] [Full Text] [Related]
31. Thrombocytopenia after combination therapy with aminoglutethimide and tamoxifen: which drug is to blame?
Ragaz J; Buskard N; Manji M
Cancer Treat Rep; 1984; 68(7-8):1015-6. PubMed ID: 6744333
[No Abstract] [Full Text] [Related]
32. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery: in regards to Toledano et al. (Int J Radiat Oncol Biol Phys 2006;65:324-332).
Munshi A; Jalali R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):314; author reply 314-5. PubMed ID: 16904531
[No Abstract] [Full Text] [Related]
33. Thrombus growth under the influence of warfarin and after abrupt reversal of its effects.
Zweifler AJ
Angiology; 1968 Mar; 19(3):135-40. PubMed ID: 5644709
[No Abstract] [Full Text] [Related]
34. Possible interaction of warfarin and stanozolol.
Shaw PW; Smith AM
Clin Pharm; 1987 Jun; 6(6):500-2. PubMed ID: 3690998
[No Abstract] [Full Text] [Related]
35. [CLINICAL TRIAL OF WARFARIN IN RETINAL VEIN THROMBOSIS].
ONO Y
Rinsho Ganka; 1964 Jan; 18():37-42. PubMed ID: 14110889
[No Abstract] [Full Text] [Related]
36. Norfloxacin and warfarin.
Linville T; Matanin D
Ann Intern Med; 1989 May; 110(9):751-2. PubMed ID: 2930115
[No Abstract] [Full Text] [Related]
37. Warfarin and topical salicylates.
Littleton F
JAMA; 1990 Jun; 263(21):2888. PubMed ID: 2338749
[No Abstract] [Full Text] [Related]
38. Potentially serious interaction of warfarin with sulphinpyrazone.
Thompson PL; Serjeant C
Med J Aust; 1981 Jan; 1(1):41. PubMed ID: 7207296
[No Abstract] [Full Text] [Related]
39. Interaction of ofloxacin and warfarin.
Baciewicz AM; Ashar BH; Locke TW
Ann Intern Med; 1993 Dec; 119(12):1223. PubMed ID: 8239258
[No Abstract] [Full Text] [Related]
40. Familial warfarin resistance in a black child.
Warrier I; Brennan CA; Lusher JM
Am J Pediatr Hematol Oncol; 1986; 8(4):346-7. PubMed ID: 3799934
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
